Discovering Patterns in Experiences of Patients in Esophageal Cancer Clinical Research
NCT05831150 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2023-04-26
Summary
Participation in clinical trials usually favors a particular demographic group. But there is limited research available to explain what study attributes affect the completion of these specific demographic groups.
This study will investigate the safety and efficacy of esophageal cancer treatments. The focus will be on tracking the rates of completion and withdrawal among these individuals.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future esophageal cancer research.
Conditions
- Esophageal Cancer
Sponsors & Collaborators
-
Power Life Sciences Inc.
lead INDUSTRY
Principal Investigators
-
Michael B Gill · Power Life Sciences Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-31
- Primary Completion
- 2025-05-31
- Completion
- 2026-05-31
More Related Trials
-
A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer
NCT00037089 ·Status: UNKNOWN ·Phase: PHASE2
-
Apatinib for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment
NCT02976896 ·Status: COMPLETED ·Phase: PHASE2
-
RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus
NCT00559351 ·Status: TERMINATED ·Phase: PHASE3
-
Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach
NCT02358863 ·Status: TERMINATED ·Phase: NA
-
Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer
NCT03120572 ·Status: COMPLETED
-
Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer
NCT01558648 ·Status: COMPLETED
-
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
NCT00109850 ·Status: TERMINATED ·Phase: PHASE2
-
Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT06888531 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Esophageal Cancer
NCT00041262 ·Status: UNKNOWN ·Phase: PHASE3
-
Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis
NCT01525953 ·Status: COMPLETED
-
Esophageal Cancer Risk Registry
NCT00260585 ·Status: RECRUITING
-
A Study of the Tumor Microenvironment Affecting the Efficacy of Immunotherapy for Esophageal Cancer
NCT06219031 ·Status: COMPLETED
-
Study of the Interest of Pursuing or Not the Chemotherapy for Patients With Metastatic Esophageal Cancer
NCT03301454 ·Status: TERMINATED ·Phase: PHASE2
-
A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
NCT06960889 ·Status: ACTIVE_NOT_RECRUITING
-
Quality Of Life Outcomes Following Treatment for Esophageal Cancer
NCT00598117 ·Status: COMPLETED
-
Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.
NCT00209716 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATION
NCT03151642 ·Status: COMPLETED
-
Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus
NCT00003321 ·Status: COMPLETED
-
Treatment Outcomes of Esophageal Cancer
NCT05177393 ·Status: RECRUITING
-
Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer.
NCT00209690 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic
NCT00533884 ·Status: COMPLETED
-
Influence Mechanism of Tumor Microenvironment Changes on Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
NCT05894369 ·Status: RECRUITING
-
S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
NCT00096031 ·Status: COMPLETED ·Phase: PHASE2
-
A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study
NCT06079723 ·Status: NOT_YET_RECRUITING
-
Positron Emission Tomography in Determining Stage of Esophageal Cancer
NCT00004867 ·Status: COMPLETED ·Phase: NA